Healthcare provider profile · identity verified

David Inger, MD

Family Practice · TOPSHAM, ME · NPI 1215941372

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	690	184
Losartan Potassium	Losartan Potassium	412	120
Lisinopril	Lisinopril	324	85
Levothyroxine Sodium	Levothyroxine Sodium	294	74
Hydrochlorothiazide	Hydrochlorothiazide	288	86
Omeprazole	Omeprazole	277	89
Rosuvastatin Calcium	Rosuvastatin Calcium	275	94
Jardiance	Empagliflozin	273	75
Amlodipine Besylate	Amlodipine Besylate	269	74
Gabapentin	Gabapentin	251	72
Escitalopram Oxalate	Escitalopram Oxalate	216	62
Tamsulosin Hcl	Tamsulosin Hcl	208	59
Zolpidem Tartrate	Zolpidem Tartrate	172	34
Metoprolol Succinate	Metoprolol Succinate	171	44
Famotidine	Famotidine	154	52
Januvia	Sitagliptin Phosphate	154	37
Duloxetine Hcl	Duloxetine Hcl	145	51
Metformin Hcl	Metformin Hcl	145	41
Lovastatin	Lovastatin	138	37
Albuterol Sulfate Hfa	Albuterol Sulfate	121	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	111	30
Tramadol Hcl	Tramadol Hcl	110	28
Metformin Hcl Er	Metformin Hcl	101	26
Oxycodone Hcl	Oxycodone Hcl	101	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	16
Metoprolol Tartrate	Metoprolol Tartrate	94	30
Pantoprazole Sodium	Pantoprazole Sodium	94	24
Sertraline Hcl	Sertraline Hcl	94	22
Allopurinol	Allopurinol	92	28
Eliquis	Apixaban	86	29
Amitriptyline Hcl	Amitriptyline Hcl	82	28
Lorazepam	Lorazepam	80	25
Citalopram Hbr	Citalopram Hydrobromide	77	22
Alendronate Sodium	Alendronate Sodium	71	25
Simvastatin	Simvastatin	71	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	21
Montelukast Sodium	Montelukast Sodium	70	23
Doxycycline Hyclate	Doxycycline Hyclate	68	46
Glipizide	Glipizide	67	21
Fluoxetine Hcl	Fluoxetine Hcl	66	18
Bupropion Xl	Bupropion Hcl	65	24
Prednisone	Prednisone	65	39
Ozempic	Semaglutide	64	11
Glipizide Er	Glipizide	63	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	62	52
Azithromycin	Azithromycin	60	50
Furosemide	Furosemide	54	15
Atenolol	Atenolol	53	16
Finasteride	Finasteride	53	15
Trazodone Hcl	Trazodone Hcl	49	20
Alprazolam	Alprazolam	47	12
Clonazepam	Clonazepam	47	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	14
Ondansetron Odt	Ondansetron	44	suppressed
Celecoxib	Celecoxib	43	12
Xarelto	Rivaroxaban	43	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	41	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	16
Fluticasone Propionate	Fluticasone Propionate	39	15
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Acyclovir	Acyclovir	36	suppressed
Fluconazole	Fluconazole	36	16
Mirtazapine	Mirtazapine	34	suppressed
Morphine Sulfate	Morphine Sulfate	34	suppressed
Amoxicillin	Amoxicillin	33	22
Warfarin Sodium	Warfarin Sodium	32	suppressed
Labetalol Hcl	Labetalol Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	21
Valacyclovir	Valacyclovir Hcl	30	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	22
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Carvedilol	Carvedilol	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Topiramate	Topiramate	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Cephalexin	Cephalexin	24	17
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Valsartan	Valsartan	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Colchicine	Colchicine	21	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Diazepam	Diazepam	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Risperidone	Risperidone	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Climara	Estradiol	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Epinephrine	Epinephrine	14	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Bupropion Hcl	Bupropion Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nystatin	Nystatin	13	suppressed
Estradiol	Estradiol	12	suppressed
Ibuprofen	Ibuprofen	12	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Baclofen	Baclofen	11	suppressed
Desmopressin Acetate	Desmopressin (Nonrefrigerated)	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nitroglycerin	Nitroglycerin	11	11
Novolog Flexpen	Insulin Aspart	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error